UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Paclitaxel, cisplatin and lonidamine in advanced ovarian cancer. A phase II study

European journal of cancer (1990), 2001-02, Vol.37 (3), p.364-368

2001

Volltextzugriff (PDF)

Phase II study of gemcitabine plus oxaliplatin as first-line chemotherapy for advanced non-small-cell lung cancer

British journal of cancer, 2005-07, Vol.93 (1), p.29-34

2005

Volltextzugriff (PDF)

Epithelial ovarian cancer: second and third line chemotherapy (review)

International journal of oncology, 2002-07, Vol.21 (1), p.179

2002

Volltextzugriff (PDF)

Rationale for the use of gemcitabine in breast cancer (Review)

International journal of oncology, 2004-02, Vol.24 (2), p.389

2004

Volltextzugriff (PDF)

Oxaliplatin plus raltitrexed and leucovorin-modulated 5-fluorouracil i.v. bolus: a salvage regimen for colorectal cancer patients

British journal of cancer, 2002-06, Vol.86 (12), p.1871-1875

2002

Volltextzugriff (PDF)

Metastatic malignant melanoma of the gallbladder: a case report and review of the literature

Melanoma research, 2002-12, Vol.12 (6), p.619-625

2002

Volltextzugriff (PDF)

Addition of either irinotecan or methotrexate to bolus 5-fluorouracil and high-dose folinic acid every 2 weeks in advanced colorectal carcinoma: a randomised study by the Southern Italy Cooperative Oncology Group

Annals of oncology, 2002-06, Vol.13 (6), p.866-873

2002

Volltextzugriff (PDF)

Pharmacokinetic Study of Intravesical Gemcitabine in Carcinoma in situ of the Bladder Refractory to Bacillus Calmette-Guérin Therapy

Urologia internationalis, 2005-01, Vol.75 (4), p.309-313

2005

Volltextzugriff (PDF)

Phase I II study of gemcitabine plus mitoxantrone as salvage chemotherapy in metastatic breast cancer

British journal of cancer, 2003-02, Vol.88 (4), p.491-495

2003

Volltextzugriff (PDF)

Phase I/II study of paclitaxel, gemcitabine and vinorelbine as first-line chemotherapy of non-small-cell lung cancer

Annals of oncology, 2002-12, Vol.13 (12), p.1862-1867

2002

Volltextzugriff (PDF)

AIDS-related non-Hodgkin's lymphoma: clinico-pathological characteristics and therapeutic strategies (review)

International journal of oncology, 2002-03, Vol.20 (3), p.611

2002

Volltextzugriff (PDF)

Current status and future potential role of exemestane in the treatment of early and advanced breast cancer (Review)

International journal of oncology, 2002-06, Vol.20 (6), p.1283

2002

Volltextzugriff (PDF)

New aromatase inhibitors in the treatment of advanced breast cancer

International journal of oncology, 2000-11, Vol.17 (5), p.1037

2000

Volltextzugriff (PDF)

Unusual Response to Second-Line Single-Agent Gemcitabine in Locally Advanced Primary Leiomyosarcoma of the Lung: A Case Report

Journal of chemotherapy (Florence), 2003-10, Vol.15 (5), p.507-509

2003

Volltextzugriff (PDF)

Tolerance profile of platinum compounds

Tumori, 2000-05, Vol.86 (3 Suppl), p.S54

2000

Volltextzugriff (PDF)

Randomised, open-label, phase II trial of paclitaxel, gemcitabine and cisplatin versus gemcitabine and cisplatin as first-line chemotherapy in advanced transitional cell carcinoma of the urothelium

Oncology reports, 2005-02, Vol.13 (2), p.283

2005

Volltextzugriff (PDF)

Single-agent pemetrexed or sequentially administered pemetrexed/gemcitabine as first-line chemotherapy for advanced non-small cell lung cancer (NSCLC) in elderly patients or patients ineligible for platinum-based chemotherapy: Preliminary results of a phase II randomized trial

Journal of clinical oncology, 2005-06, Vol.23 (16_suppl), p.7156-7156

2005

Volltextzugriff (PDF)

Amifostine as chemoprotectant in metastatic breast cancer patients treated with doxorubicin

Oncology reports, 2003-01, Vol.10 (1), p.163

2003

Volltextzugriff (PDF)

P-488 Phase II randomized trial of single-agent pemetrexed orsequentially administered pemetrexed/gemcitabine as front-line chemotherapy for the treatment of advanced non-small cell lung cancer (NSCLC) in elderly patients or patients ineligible for platinum-based chemotherapy

Lung cancer (Amsterdam, Netherlands), 2005-07, Vol.49, p.S245-S245

2005

Volltextzugriff (PDF)

The role of letrozole (Femara(R)) in breast cancer therapy: A clinical review

Drugs of Today, 2001-09, Vol.37 (9), p.639

2001

Volltextzugriff (PDF)

O-143 Gemcitabine-oxaliplatin (GEMOX) chemotherapy as first-line treatment in advanced non-small cell lung cancer (NSCLC): Preliminary results of a multicenter phase II study

Lung cancer (Amsterdam, Netherlands), 2003-08, Vol.41, p.S44-S44

2003

Volltextzugriff (PDF)

Addition of either irinotecan or methotrexate to bolus5-fluorouracil and high-dose folinic acid every 2 weeks in advanced colorectal carcinoma: a randomised study by the Southern Italy Cooperative Oncology Group

Annals of oncology, 2002-06, Vol.13 (6), p.866-873

2002

Volltextzugriff (PDF)

Taxol-gemcitabine-vinorelbine (TGV) given every 2 weeks in chemo-naive advanced NSCLC. A SICOG phase I study

European journal of cancer (1990), 2001-04, Vol.37, p.S49-S49

2001

Volltextzugriff (PDF)

Oxaliplatin (L-OHP) and irinotecan (CPT-11) with 6s-leucovorin (IFA)-modulated 5-fluorouracil (FU) i.v. bolus every 2 weeks: a dose-finding study in patients (pts) with gastrointestinal malignancies

European journal of cancer (1990), 2001-04, Vol.37, p.S302-S302

2001

Volltextzugriff (PDF)

Biweekly irinotecan (IRI) with 6s-folinic acid (FA)-modulated 5-fluorouracil (FU) i.v. bolus in advanced colorectal carcinoma (ACC): a phase III study

European journal of cancer (1990), 2001-04, Vol.37, p.S302-S302

2001

Volltextzugriff (PDF)

1 – 25 von 45

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(35)
Mit Volltextzugriff
(35)

Publikationsform

Artikel
(45)

Sprache

Erscheinungsjahr

n.n

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Paclitaxel, cisplatin and lonidamine in advanced ovarian cancer. A phase II study

Phase II study of gemcitabine plus oxaliplatin as first-line chemotherapy for advanced non-small-cell lung cancer

Epithelial ovarian cancer: second and third line chemotherapy (review)

Rationale for the use of gemcitabine in breast cancer (Review)

Oxaliplatin plus raltitrexed and leucovorin-modulated 5-fluorouracil i.v. bolus: a salvage regimen for colorectal cancer patients

Metastatic malignant melanoma of the gallbladder: a case report and review of the literature

Addition of either irinotecan or methotrexate to bolus 5-fluorouracil and high-dose folinic acid every 2 weeks in advanced colorectal carcinoma: a randomised study by the Southern Italy Cooperative Oncology Group

Pharmacokinetic Study of Intravesical Gemcitabine in Carcinoma in situ of the Bladder Refractory to Bacillus Calmette-Guérin Therapy

Phase I II study of gemcitabine plus mitoxantrone as salvage chemotherapy in metastatic breast cancer

Phase I/II study of paclitaxel, gemcitabine and vinorelbine as first-line chemotherapy of non-small-cell lung cancer

AIDS-related non-Hodgkin's lymphoma: clinico-pathological characteristics and therapeutic strategies (review)

Current status and future potential role of exemestane in the treatment of early and advanced breast cancer (Review)

New aromatase inhibitors in the treatment of advanced breast cancer

Unusual Response to Second-Line Single-Agent Gemcitabine in Locally Advanced Primary Leiomyosarcoma of the Lung: A Case Report

Tolerance profile of platinum compounds

Randomised, open-label, phase II trial of paclitaxel, gemcitabine and cisplatin versus gemcitabine and cisplatin as first-line chemotherapy in advanced transitional cell carcinoma of the urothelium

Single-agent pemetrexed or sequentially administered pemetrexed/gemcitabine as first-line chemotherapy for advanced non-small cell lung cancer (NSCLC) in elderly patients or patients ineligible for platinum-based chemotherapy: Preliminary results of a phase II randomized trial

Amifostine as chemoprotectant in metastatic breast cancer patients treated with doxorubicin

P-488 Phase II randomized trial of single-agent pemetrexed orsequentially administered pemetrexed/gemcitabine as front-line chemotherapy for the treatment of advanced non-small cell lung cancer (NSCLC) in elderly patients or patients ineligible for platinum-based chemotherapy

The role of letrozole (Femara(R)) in breast cancer therapy: A clinical review

O-143 Gemcitabine-oxaliplatin (GEMOX) chemotherapy as first-line treatment in advanced non-small cell lung cancer (NSCLC): Preliminary results of a multicenter phase II study

Addition of either irinotecan or methotrexate to bolus5-fluorouracil and high-dose folinic acid every 2 weeks in advanced colorectal carcinoma: a randomised study by the Southern Italy Cooperative Oncology Group

Taxol-gemcitabine-vinorelbine (TGV) given every 2 weeks in chemo-naive advanced NSCLC. A SICOG phase I study

Oxaliplatin (L-OHP) and irinotecan (CPT-11) with 6s-leucovorin (IFA)-modulated 5-fluorouracil (FU) i.v. bolus every 2 weeks: a dose-finding study in patients (pts) with gastrointestinal malignancies

Biweekly irinotecan (IRI) with 6s-folinic acid (FA)-modulated 5-fluorouracil (FU) i.v. bolus in advanced colorectal carcinoma (ACC): a phase III study

Suchergebnisse filtern